Loading
Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
A radiation treatment plan can document the prescription, target volumes, organs at risk, treatment technique, dose per fraction, number of fractions, beam or source arrangement, dose distribution, and dose constraints intended to limit exposure to normal tissues. The radiation oncologist defines the treatment intent, target volumes, prescription, and relevant normal-tissue constraints, while treatment-planning systems and the radiation oncology team translate those requirements into a deliverable dose distribution. Reviewing the prescription, contours, dose-volume information, and approved plan can therefore show not only how much radiation was prescribed but also where the dose was intended to go and which structures were being protected.
No. Radiation treatment is designed to deliver an effective dose to a target while limiting exposure to surrounding normal tissues, but some normal-tissue dose may be unavoidable. A reported toxicity should be considered in relation to the treatment site, dose and fractionation, volume of normal tissue exposed, applicable dose constraints, timing of symptoms, concurrent or prior treatments, patient factors, and the known toxicity profile of the treatment. The occurrence of toxicity alone does not establish that the treatment plan or delivery was inappropriate.
Fractionation describes how the prescribed radiation dose is divided among treatment sessions. Conventional schedules generally use more treatments with smaller doses per fraction, while hypofractionated and stereotactic approaches use fewer treatments with larger doses per fraction. Selection depends on the cancer type, treatment goal, target size and location, nearby sensitive structures, previous radiation, and other therapies. Because total dose, dose per fraction, and treatment schedule all influence tumor and normal-tissue effects, two radiation courses cannot be meaningfully compared solely by the number of treatment sessions.
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.
No. Stereotactic radiosurgery, or SRS, is a highly focused form of external-beam radiation therapy and does not involve a surgical incision. It is primarily used for selected intracranial targets and relies on precise localization, immobilization or image guidance, and highly conformal radiation delivery. SRS was traditionally defined as treatment delivered in a single fraction, while contemporary practice also uses fractionated stereotactic approaches for some cranial lesions, sometimes described as fractionated SRS or stereotactic radiotherapy.
The approved treatment plan documents the intended course, but the course may later be interrupted, modified, or replanned because of anatomical changes, tumor response, toxicity, positioning concerns, prior dose information, or other clinical developments. The prescription, approved plans, image-guidance records, treatment-delivery logs, delivered fractions, and any adaptive or revised plans can help reconstruct what treatment was actually delivered. Comparing these records can distinguish an intentional clinical modification from an unintended discrepancy between planned and delivered treatment.
